These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9864077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N, Greil W.
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [Abstract] [Full Text] [Related]

  • 3. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
    Greil W, Kleindienst N.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
    [Abstract] [Full Text] [Related]

  • 4. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W, Kleindienst N.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [Abstract] [Full Text] [Related]

  • 5. Predictors of response to mood stabilizers.
    Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ.
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
    [Abstract] [Full Text] [Related]

  • 6. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM.
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [Abstract] [Full Text] [Related]

  • 7. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L.
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC, Laini V, Scalvini ME, Volonteri LS, Ferrari MS, Panza G.
    Eur Rev Med Pharmacol Sci; 1999 Apr; 3(2):63-9. PubMed ID: 10827806
    [Abstract] [Full Text] [Related]

  • 11. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 12. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F, Nolen WA, Hoenderboom AC, Kupka RW.
    Ned Tijdschr Geneeskd; 2000 Feb 26; 144(9):401-4. PubMed ID: 10719540
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
    Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O'Donovan C, Teehan A, Alda M.
    J Affect Disord; 2007 Dec 26; 104(1-3):185-90. PubMed ID: 17442400
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD004857. PubMed ID: 22161387
    [Abstract] [Full Text] [Related]

  • 17. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
    Denicoff KD, Smith-Jackson EE, Bryan AL, Ali SO, Post RM.
    Am J Psychiatry; 1997 Oct 07; 154(10):1456-8. PubMed ID: 9326833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.